Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib was effective for severe, treatment-resistant hair loss without side effects.

Flutamide effectively reduced excessive hair growth and improved related symptoms in hirsutism patients without significant side effects.

CDK inhibitors may help treat ARDS and psoriasis but need more testing for safety and effectiveness.

New treatments for atopic dermatitis and alopecia areata have been developed using a targeted approach.

Antihelminthic drugs treat worm infections but face challenges like low treatment coverage and potential drug resistance, with various side effects reported for different drugs.

The AC 2 peptide from Trapa japonica fruit helps protect hair cells and may treat hair loss.

Dihydroartemisinin helps reduce prostate enlargement in rats by stopping the growth of prostate cells.

Blocking α-toxin helps heal Staphylococcus aureus-infected wounds faster in both normal and diabetic mice, with different effects on their immune responses.

Targeting NETs may help reduce fibrosis in Crohn's disease.

Dyclonine can effectively reduce skin issues by inhibiting the TRPV3 channel.

Co-trimoxazole may help treat autoimmune diseases.

Selective non-steroidal inhibitors of 5α-reductase type 1 can help treat DHT-related disorders.

CD8+ T cells play a key role in graft-versus-host disease in certain mice models.

New compounds called benzoquinolinones may treat conditions linked to excess DHT.

T-cell reconstitution after thymus transplantation can cause hair whitening and loss.

Betamethasone can effectively treat alopecia areata.

New progesterone-based compounds can block male hormones.

Both penicillamine and tiopronin have significant side effects, but trying the alternative drug can be beneficial if the first is not tolerated.

AP-1 and TGFß work together to drive resistance in basal cell carcinoma, suggesting new treatment options.

Oral betamethasone works faster than oral tofacitinib for hair regrowth in alopecia areata.

HKN-2 antibody targets specific skin and hair cells, showing keratin complexity.

New compounds were made and tested, with compound 6 showing potential for treating prostate-related diseases.

LHTric-1 is a specific antibody useful for studying hair and nail formation.

Cyclosporin A, a drug, reduces TGF-β2 expression in skin cells, potentially causing excessive hair growth through a process involving the calcineurin/NFAT pathway.

The drug TGU was ineffective against small cell lung cancer and caused significant bone marrow suppression.

Higher levels of IL-17A and IL-2 are linked to alopecia areata.

α-MSH may help treat skin inflammation and fibrosis.

Tislelizumab can cause cutaneous lupus erythematosus.

Triamcinolone acetonide and betamethasone 1.75 mg/ml are both effective for treating alopecia areata.

Certain HLA class II alleles increase or decrease the risk of alopecia areata.